Soleo Health Selected as Exclusive In-Network Specialty Pharmacy for Qfitlia™ a Treatment Option for Adults With Hemophilia A and B With and Without Inhibitors

Company Chosen in Part Based on Its Extensive Experience in Supporting Patients with Bleeding Disorders

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named the exclusive in-network specialty pharmacy for Qfitlia™ (fitusiran) by Sanofi, an innovative global healthcare company. Soleo Health will be the specialty pharmacy to dispense Qfitlia, the first antithrombin-lowering therapy for hemophilia.* The US Food and Drug Administration has recently approved its use for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients (aged 12 or older) with hemophilia A or B with or without factor VIII or IX inhibitors.

Drew Walk, Soleo Health’s chief executive officer, commented: "We are pleased to be selected by Sanofi to help bring its first-of-its-kind hemophilia medication to patients. Therapies like Qfitlia can have a significant impact on patients living with hemophilia and we look forward to supporting patients who will benefit from this innovative treatment option. Our team continues to work collaboratively with our pharma partners to bring ground-breaking medical treatments to patients to make a meaningful impact on their lives.”

For more information on receiving Qfitlia therapy and support services through Soleo Health, contact the Company at phone: 844.747.4040, fax: 844.797.5050 or email: bleedingdisorders@soleohealth.com.

*Patients may also be able to have Qfitlia dispensed at their local hemophilia treatment provider.

About Soleo Health

Frisco, Texas-based Soleo Health is a leading, independent national provider of complex specialty pharmacy services and infusion therapy administered in the home or at alternate sites of care. Soleo Health’s interdisciplinary team comprises highly experienced clinical pharmacists, registered nurses, reimbursement specialists and patient care ambassadors collaborating with its referring partners.

The Company optimizes patient care solutions and delivers comprehensive services, leading to quantifiable clinical and economic value, resulting in positive patient experiences. Soleo Health has 26 pharmacy locations with national nursing coverage and pharmacy licensure in 50 states and is accredited by URAC, ACHC with Distinction in Rare Disease and Orphan Drugs and the National Association of Boards of Pharmacy. Additionally, the Company operates more than 30 infusion suites and centers throughout the U.S.

Visit www.soleohealth.com or connect with Soleo Health on LinkedIn, Facebook and X for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250414966770/en/

Soleo Health named exclusive in-network specialty pharmacy for Qfitlia™ (fitusiran) by Sanofi.